|
MechanismSNAP25 inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.DE |
First Approval Date24 Oct 2007 |
100 Clinical Results associated with Merz Australia Pty Ltd
0 Patents (Medical) associated with Merz Australia Pty Ltd
100 Deals associated with Merz Australia Pty Ltd
100 Translational Medicine associated with Merz Australia Pty Ltd